222 related articles for article (PubMed ID: 26508412)
1. Targeted anticancer drug delivery through anthracycline antibiotic bearing functionalized quantum dots.
Bajwa N; Kumar Mehra N; Jain K; Kumar Jain N
Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1774-82. PubMed ID: 26508412
[TBL] [Abstract][Full Text] [Related]
2. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
[TBL] [Abstract][Full Text] [Related]
3. 'One-pot' synthesis of multifunctional GSH-CdTe quantum dots for targeted drug delivery.
Chen X; Tang Y; Cai B; Fan H
Nanotechnology; 2014 Jun; 25(23):235101. PubMed ID: 24849381
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-conjugated D-glucosamine- and folate- bi-functionalised InP/ZnS quantum dots for cancer cells imaging and therapy.
Ranjbar-Navazi Z; Eskandani M; Johari-Ahar M; Nemati A; Akbari H; Davaran S; Omidi Y
J Drug Target; 2018 Mar; 26(3):267-277. PubMed ID: 28795849
[TBL] [Abstract][Full Text] [Related]
5. CuInS(2) quantum dots/poly((L)-glutamic acid)-drug conjugates for drug delivery and cell imaging.
Gao X; Liu Z; Lin Z; Su X
Analyst; 2014 Feb; 139(4):831-6. PubMed ID: 24418901
[TBL] [Abstract][Full Text] [Related]
6. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
7. Intracellularly Actuated Quantum Dot-Peptide-Doxorubicin Nanobioconjugates for Controlled Drug Delivery via the Endocytic Pathway.
Sangtani A; Petryayeva E; Wu M; Susumu K; Oh E; Huston AL; Lasarte-Aragones G; Medintz IL; Algar WR; Delehanty JB
Bioconjug Chem; 2018 Jan; 29(1):136-148. PubMed ID: 29191007
[TBL] [Abstract][Full Text] [Related]
8. A graphene quantum dot@Fe
Su X; Chan C; Shi J; Tsang MK; Pan Y; Cheng C; Gerile O; Yang M
Biosens Bioelectron; 2017 Jun; 92():489-495. PubMed ID: 27839733
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model.
Zavvar T; Babaei M; Abnous K; Taghdisi SM; Nekooei S; Ramezani M; Alibolandi M
Int J Pharm; 2020 Mar; 578():119091. PubMed ID: 32007591
[TBL] [Abstract][Full Text] [Related]
10. One platform comparison of estrone and folic acid anchored surface engineered MWCNTs for doxorubicin delivery.
Mehra NK; Jain NK
Mol Pharm; 2015 Feb; 12(2):630-43. PubMed ID: 25517904
[TBL] [Abstract][Full Text] [Related]
11. Effect of functionalization on drug delivery potential of carbon nanotubes.
Sharma S; Mehra NK; Jain K; Jain NK
Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1851-1860. PubMed ID: 26732473
[TBL] [Abstract][Full Text] [Related]
12. Rapid fabrication of carbon quantum dots as multifunctional nanovehicles for dual-modal targeted imaging and chemotherapy.
Chiu SH; Gedda G; Girma WM; Chen JK; Ling YC; Ghule AV; Ou KL; Chang JY
Acta Biomater; 2016 Dec; 46():151-164. PubMed ID: 27662808
[TBL] [Abstract][Full Text] [Related]
13. PEGylated MoS
Liu L; Jiang H; Dong J; Zhang W; Dang G; Yang M; Li Y; Chen H; Ji H; Dong L
Colloids Surf B Biointerfaces; 2020 Jan; 185():110590. PubMed ID: 31670002
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-mediated green synthesis and folic-acid modification of CuS quantum dots for photoacoustic imaging guided photothermal therapy of tumor.
Yu W; Yu N; Wang Z; Li X; Song C; Jiang R; Geng P; Li M; Yin S; Chen Z
J Colloid Interface Sci; 2019 Nov; 555():480-488. PubMed ID: 31401480
[TBL] [Abstract][Full Text] [Related]
16. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
17. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes.
Mehra NK; Jain NK
J Drug Target; 2013 Sep; 21(8):745-58. PubMed ID: 23822734
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery.
Li Y; Wang M; Huang BW; Ping Y; You J; Gao JQ
Int J Nanomedicine; 2017; 12():8557-8572. PubMed ID: 29238192
[TBL] [Abstract][Full Text] [Related]
19. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
Shen Z; Li Y; Kohama K; Oneill B; Bi J
Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
[TBL] [Abstract][Full Text] [Related]
20. pH-Sensitive ZnO Quantum Dots-Doxorubicin Nanoparticles for Lung Cancer Targeted Drug Delivery.
Cai X; Luo Y; Zhang W; Du D; Lin Y
ACS Appl Mater Interfaces; 2016 Aug; 8(34):22442-50. PubMed ID: 27463610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]